Main demographic, clinical, and laboratory features of 112 patients with aPL antibodies at entry in the WAPS Study
| Features . | Data . |
|---|---|
| Sex, no. male/no. female | 24/88 |
| Age, y | |
| Median | 42 |
| Range | 23-83 |
| Autoimmune diseases, no. (%) | 32 (28.6) |
| Systemic lupus erythematosus | 21 |
| Autoimmune hemolytic anemia | 5 |
| Autoimmune thyroyditis | 2 |
| Sjogren syndrome | 2 |
| Miscellanea | 8 |
| Anamnestic thrombosis, no. (%) | 81 (72.3) |
| Deep vein thrombosis | 46 |
| Arterial thrombosis | 30 |
| Both deep vein and arterial thrombosis | 5 |
| Anamnestic spontaneous miscarriage, n≥1, no. (%) | 17 (19.3) |
| Antiphospholipid syndrome, no. (%) | 87 (77.7) |
| LAs*, no. (%) | 91 (81.3) |
| aCL antibodies; no. of patients tested, 104*, no. (%) | 57† (54.8) |
| IgG at least 40 GPL units | 49 |
| IgM at least 40 MPL units | 14 |
| Features . | Data . |
|---|---|
| Sex, no. male/no. female | 24/88 |
| Age, y | |
| Median | 42 |
| Range | 23-83 |
| Autoimmune diseases, no. (%) | 32 (28.6) |
| Systemic lupus erythematosus | 21 |
| Autoimmune hemolytic anemia | 5 |
| Autoimmune thyroyditis | 2 |
| Sjogren syndrome | 2 |
| Miscellanea | 8 |
| Anamnestic thrombosis, no. (%) | 81 (72.3) |
| Deep vein thrombosis | 46 |
| Arterial thrombosis | 30 |
| Both deep vein and arterial thrombosis | 5 |
| Anamnestic spontaneous miscarriage, n≥1, no. (%) | 17 (19.3) |
| Antiphospholipid syndrome, no. (%) | 87 (77.7) |
| LAs*, no. (%) | 91 (81.3) |
| aCL antibodies; no. of patients tested, 104*, no. (%) | 57† (54.8) |
| IgG at least 40 GPL units | 49 |
| IgM at least 40 MPL units | 14 |